Novasep Upgrades Mourenx Site
Novasep (Lyon, France) has announced a €6.1 million investment in its Mourenx site, Pyrénées-Atlantiques, France, to modernize its API manufacturing facility.
The modernization of the cGMP workshop includes the installation of new equipment and the revamping of clean rooms for API isolation, enhancing Novasep’s flexibility and developing capacity for the custom manufacturing of innovative therapeutic molecules. Additionally, Novasep has also announced the creation of seven full-time jobs on this site.
This project has been selected as part of the France Relance recovery plan initiated by the French government. Novasep will be supported within the framework of the “Investissements d’Avenir” (Investments for the future) programme, which rewards innovative and promising industrial investments.
“This investment sends a strong signal to our customers and partners by increasing our market competitiveness. It further supports our strategy of reinforcing our high-quality offer for the commercial production of innovative therapies,” said Michel Spagnol, Chairman and CEO of Novasep.
For more information please visit: www.novasep.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Investigating Plastic Contamination in Olive Oil with GC–MS/MS
January 17th 2025The objective of this study was to investigate contamination by 32 plasticizers in olive oil throughout its production and packaging process. Separation and detection were carried out by gas chromatography tandem mass spectrometry (GC–MS/MS), without the need for pre-concentration steps.
Top Execs from Agilent, Waters, and Bruker Take the Stage at J.P. Morgan Healthcare Conference
January 16th 2025The 43rd Annual Healthcare J.P. Morgan Healthcare Conference kicked off in San Francisco earlier this week. Here’s what top executives from Agilent, Bruker, and Waters, discussed during the event.
